John Rakow

2022

In 2022, John Rakow earned a total compensation of $1M as Former Acting Chief Financial Officer at Avalanche Biotechnologies.

Compensation breakdown

Non-Equity Incentive Plan$204,750
Option Awards$378,528
Salary$430,739
Other$11,200
Total$1,025,217

Rakow received $430.7K in salary, accounting for 42% of the total pay in 2022.

Rakow also received $204.8K in non-equity incentive plan, $378.5K in option awards and $11.2K in other compensation.

Rankings

In 2022, John Rakow's compensation ranked 2,973rd out of 5,753 executives tracked by ExecPay. In other words, Rakow earned more than 48.3% of executives.

ClassificationRankingPercentile
All
2,973
out of 5,753
48th
Division
Manufacturing
1,665
out of 3,133
47th
Major group
Chemicals And Allied Products
776
out of 1,419
45th
Industry group
Drugs
725
out of 1,320
45th
Industry
Biological Products, Except Diagnostic Substances
174
out of 291
40th

Pay ratio

John Rakow's Pay$1,025,217
Median Employee's Pay$169,590
Pay Ratio

6

to 1

In 2022, the annual total compensation of John Rakow was $1,025,217.

The annual total compensation of the median employee at Avalanche Biotechnologies was $169,590.

The ratio of John Rakow's pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on April 25, 2023.

Rakow's colleagues

We found six more compensation records of executives who worked with John Rakow at Avalanche Biotechnologies in 2022.

2022

Laurent Fischer

Avalanche Biotechnologies

Chief Executive Officer

2022

Setareh Seyedkazemi

Avalanche Biotechnologies

Chief Development Officer

2022

Richard Beckman

Avalanche Biotechnologies

Chief Medical Officer

2022

Kishor Soparkar

Avalanche Biotechnologies

Chief Operating Officer

2022

Rupert D'Souza

Avalanche Biotechnologies

Chief Financial Officer

2022

Linda Rubinstein

Avalanche Biotechnologies

Chief Financial Officer

News

You may also like